Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1986 | 09-1986 | 09-1985 | 09-1984 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 3,573 | 7,299 | 850 | -184 |
| Marketable Securities | 5,256 | 3,701 | 507 | 770 |
| Receivables | 510 | 435 | 382 | 301 |
| Inventories | 190 | 168 | 89 | 43 |
| Other current assets | 24 | 16 | 9 | 4 |
| TOTAL | $9,552 | $11,620 | $1,837 | $934 |
| Non-Current Assets | ||||
| PPE Net | 2,826 | 296 | 197 | 148 |
| Other Non-Current Assets | 165 | 448 | 151 | 192 |
| TOTAL | $2,992 | $744 | $349 | $340 |
| Total Assets | $12,355 | $12,205 | $2,079 | $1,208 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 101 | 81 | 47 | 81 |
| Accrued Expenses | 13 | 54 | 11 | 19 |
| Other current liabilities | 83 | 83 | 0 | 0 |
| TOTAL | $273 | $368 | $403 | $323 |
| Non-Current Liabilities | ||||
| TOTAL | $36 | $36 | $31 | $41 |
| Total Liabilities | $309 | $404 | $434 | $364 |
| Shareholders' Equity | ||||
| Common Shares | 30 | 30 | 19 | 21 |
| Retained earnings | 2,176 | 1,931 | 1,127 | 226 |
| TOTAL | $12,046 | $11,801 | $1,645 | $844 |
| Total Liabilities And Equity | $12,355 | $12,205 | $2,079 | $1,208 |